← Back
$DNTH All transactions

Dianthus Therapeutics, Inc. /DE/

A

$ Value

$0

Shares

12,500

Price

$0

Filed

May 22

Insider

Name

Lawton Alison Frances

Title

CIK

0001542650

Roles

Director

Transaction Details

Transaction Date

2025-05-22

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

12,500

Footnotes

The shares of common stock underlying this stock option award will vest in full on the date that is the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through the vesting date.

Filing Info

Accession No.

0000950170-25-076403

Form Type

4

Issuer CIK

0001690585

Lawton Alison Frances's History

Date Ticker Type Value
2025-05-22 DNTH A $0

Other Insiders at DNTH (90d)

Insider Bought Sold Last
CARR EDWARD
CHIEF ACCOUNTING OFFICER
$3.6M 2026-03-12
Garcia Marino
CEO AND PRESIDENT
$10.0M 2026-03-16
Soteropoulos Paula $2.2M 2026-03-31
Veness Adam M
SVP, General Counsel and Sec.
2026-02-03
Randhawa Simrat
EVP, Head of R&D
$2.8M 2026-03-12
Savitz Ryan
EVP, CFO & CBO
$10.2M 2026-04-09